Dr. Kanwardeep Singh Sachdeva, MD

Dr. Sachdeva practices at U.S. Renal Care Southwest Mesa Dialysis in Phoenix, Arizona.

Dr. Sachdeva's NPI, 1457675134, was assigned on March 24, 2010. Dr. Sachdeva holds Arizona license 43044.

Dr. Sachdeva's primary practice is U.S. Renal Care Southwest Mesa Dialysis, at 612 W Baseline Rd, Phoenix, AZ 85041 in Maricopa County. The practice phone is (480) 894-5411.

Dr. Sachdeva's primary practice is U.S. Renal Care Southwest Mesa Dialysis in Phoenix, Arizona. The medical group on file is Desert Kidney Associates. Dmand AI also links Dr. Sachdeva to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sachdeva practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sachdeva's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Sachdeva's licenses on file in 2 states: Arizona and Texas.

CMS data shows 2,578 Medicare services from Dr. Sachdeva across 18 procedure codes in 2024, for 353 Medicare patients. Medicare paid $142,473 for them.

CMS counts 353 Medicare patients who saw Dr. Sachdeva in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sachdeva's median patient age at 70, with 49% women.

In 2024, Dr. Sachdeva wrote 1,400 Medicare Part D claims for 261 patients. 86% of them were for generic drugs. CMS names the drug for 1,191 of them, across 31 drugs with 11 or more claims each, at $105,667 in total drug cost. In 2023, CMS named 1,426 claims across 33 drugs.

Dr. Sachdeva accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 101 general payments to Dr. Sachdeva from 27 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $446.